Gene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart

• Published in: European heart journal open 2024-05, Vol.4 (3), p.oeae034
• Main Authors: Kane, Mariame Selma, Juncos, Juan Xavier Masjoan, Manzoor, Shajer, Grenett, Maximiliano, Oh, Joo-Yeun, Pat, Betty, Ahmed, Mustafa I, Lewis, Clifton, Davies, James E, Denney, Thomas S, McConathy, Jonathan, Dell'Italia, Louis J
• Format: Article
• Language: English
• Subjects: Complications and side effects; Development and progression; Fatty acid metabolism; Genetic aspects; Glucose metabolism; Health aspects; Mitral valve insufficiency; Original
• ISSN: 2752-4191; 2752-4191
• DOI: 10.1093/ehjopen/oeae034

Chronic neurohormonal activation and haemodynamic load cause derangement in the utilization of the myocardial substrate. In this study, we test the hypothesis that the primary mitral regurgitation (PMR) heart shows an altered metabolic gene profile and cardiac ultra-structure consistent with decreased fatty acid and glucose metabolism despite a left ventricular ejection fraction (LVEF) > 60%. Metabolic gene expression in right atrial (RA), left atrial (LA), and left ventricular (LV) biopsies from donor hearts ( = 10) and from patients with moderate-to-severe PMR ( = 11) at surgery showed decreased mRNA glucose transporter type 4 (GLUT4), GLUT1, and insulin receptor substrate 2 and increased mRNA hexokinase 2, O-linked -acetylglucosamine transferase, and O-linked -acetylglucosaminyl transferase, rate-limiting steps in the hexosamine biosynthetic pathway. Pericardial fluid levels of neuropeptide Y were four-fold higher than simultaneous plasma, indicative of increased sympathetic drive. Quantitative transmission electron microscopy showed glycogen accumulation, glycophagy, increased lipid droplets (LDs), and mitochondrial cristae lysis. These findings are associated with increased mRNA for glycogen synthase kinase 3β, decreased carnitine palmitoyl transferase 2, and fatty acid synthase in PMR vs. normals. Cardiac magnetic resonance and positron emission tomography for 2-deoxy-2-[ F]fluoro-D-glucose ([ F]FDG) uptake showed decreased LV [ F]FDG uptake and increased plasma haemoglobin A1C, free fatty acids, and mitochondrial damage-associated molecular patterns in a separate cohort of patients with stable moderate PMR with an LVEF > 60% ( = 8) vs. normal controls ( = 8). The PMR heart has a global ultra-structural and metabolic gene expression pattern of decreased glucose uptake along with increased glycogen and LDs. Further studies must determine whether this presentation is an adaptation or maladaptation in the PMR heart in the clinical evaluation of PMR.